These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10938480)

  • 1. Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies.
    Swedberg K
    Eur J Heart Fail; 2000 Sep; 2(3):229-33. PubMed ID: 10938480
    [No Abstract]   [Full Text] [Related]  

  • 2. Ivabradine and outcomes in chronic heart failure.
    Gupta A; Sharma YP
    Lancet; 2010 Dec; 376(9758):2069; author reply 2069-70. PubMed ID: 21168044
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic heart failure: progress in diagnosis and treatment. Topics: III. Progress in prevention, control and treatment: 3. Evidence-based pharmacologic therapy for chronic heart failure].
    Kinugawa K
    Nihon Naika Gakkai Zasshi; 2012 Feb; 101(2):379-86. PubMed ID: 22523807
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of chronic heart failure.
    Packer M
    Lancet; 1992 Jul; 340(8811):92-5. PubMed ID: 1352023
    [No Abstract]   [Full Text] [Related]  

  • 5. Aldosterone antagonism in heart failure.
    Richards AM; Nicholls MG
    Lancet; 1999 Sep; 354(9181):789-90. PubMed ID: 10485716
    [No Abstract]   [Full Text] [Related]  

  • 6. What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Tajik AA; Dickstein K
    Heart; 2016 Dec; 102(23):1922-1932. PubMed ID: 27742799
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug treatment of chronic heart failure].
    Böhm M; Werner N; Kindermann M
    Clin Res Cardiol; 2006; 95 Suppl 4():36-54; quiz 55-6. PubMed ID: 16598606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Congestive heart failure, part 2: treatment].
    Smith JG; Kohl S; Kornhall B; Ekmehag B
    Lakartidningen; 2012 Oct 10-16; 109(41):1829-34. PubMed ID: 23173405
    [No Abstract]   [Full Text] [Related]  

  • 9. A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.
    Voors AA; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Lang CC; Ter Maaten JM; Ng L; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zannad F; Zwinderman AH; Metra M
    Eur J Heart Fail; 2016 Jun; 18(6):716-26. PubMed ID: 27126231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
    Lim WY; Woldman S
    Br J Hosp Med (Lond); 2013 Feb; 74(2):C18-22. PubMed ID: 23411909
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?
    van der Horst IC; Voors AA; van Veldhuisen DJ
    Clin Res Cardiol; 2007 Apr; 96(4):193-5. PubMed ID: 17294352
    [No Abstract]   [Full Text] [Related]  

  • 12. Recommended Heart Failure Medications and Adverse Drug Reactions in Women.
    Bots SH; den Ruijter HM
    Circulation; 2019 Mar; 139(12):1469-1471. PubMed ID: 30883224
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
    MMW Fortschr Med; 2010 Dec; 152(48):12-3. PubMed ID: 21226226
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
    MMW Fortschr Med; 2005 Jul; 147(27-28):44. PubMed ID: 16041942
    [No Abstract]   [Full Text] [Related]  

  • 15. Guideline-Directed Medical Therapy Clinics: A Call to Action for the Heart Failure Team.
    O'Connor CM
    JACC Heart Fail; 2019 May; 7(5):442-443. PubMed ID: 31047024
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of Hyperkalemia and Worsening Renal Function on the Use of Renin Angiotensin Aldosterone System Inhibitors in Chronic Heart Failure With Reduced Ejection Fraction.
    Pitt B; Rossignol P
    Clin Pharmacol Ther; 2017 Sep; 102(3):389-391. PubMed ID: 28707341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of chronic heart failure.
    Adorisio R; De Luca L; Rossi J; Gheorghiade M
    Heart Fail Rev; 2006 Jun; 11(2):109-23. PubMed ID: 16937030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in pharmacotherapy of hospitalized patients with heart failure for 16 years].
    Savina NM; Aleksandrova AIu; Sidorenko BA
    Kardiologiia; 2010; 50(6):53. PubMed ID: 20659028
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.